References
- Banchereau J., Briere F., et al. Imunobiology of dendritic cells. Annu. Rev. Immunol. 2000; 18: 767–811
- Banchereau J., Pascual V., et al. Autoimmunity through cytokine-induced dendritic cell activation. Immunity. 2004; 20: 539–550
- Brock J. H. Lactoferrin: a multifunctional immunoregulatory protein?. Immunol Today 1995; 16: 417–419
- Dupuis M., Denis-Mize K., et al. Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis. Eur. J. Immunol. 2001; 31: 2910–2918
- Feldman M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2002; 2: 364–371
- Foong W. C., Green K. L. Treatment of antigen-induced arthritis in rabbits with liposome-entrapped methotrexate injected intra-articularly. J. Pharm. Pharmacol 1993; 45: 204–209
- Gomez-Barrena E., Lindroos L., et al. Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis. Clin. Exp. Rheumatol 2006; 24: 622–628
- Guillén C., McInnes I. B., et al. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum 2000; 43: 2073–2080
- Ito T., Yang M., et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med. 2007; 204: 105–115
- Keystone E. C., Wherry J., et al. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum. Dis. Clin. North. Am 1998; 24: 629–639
- Konigsberg P. J., Debrick, et al. Liposome encapsulated aurothiomalate reduces collagen-induced arthritis in DBA/1J mice. Biochim. Biophys. Acta 1999; 1421: 149–162
- Lee D. M., Weinblatt M. E. Rheumatoid arthritis. Lancet 2001; 358: 903–911
- Leung P. B., Conacher M., et al. A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. J. Immunol. 2002; 169: 7071–7077
- López-García F., Vásquez-Auton J. M., et al. Intra-articular therapy of experimental arthritis with a derivative of triamcinolone acetonide incorporated in liposomes. J. Pharm. Pharmacol. 1993; 45: 576–578
- Lutz M. B., Kukutsch N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Method 2004; 223: 77–92
- Metselaar J. M., van den Berg W. B., et al. Liposomal targeting glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheum. Dis. 2004; 63: 348–353
- Millington O. R., Di Lorenzo C., et al. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cells. J. Biol. 2004; 5: 5
- Novak N. Targeting dendritic cells in allergen immunotherapy. Immunol Allergy Clin North Am 2006; 26: 307–319
- Pick U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch. Biochem. Biophys. 1981; 212: 186–194
- Smith M. K., Brewer M. J., et al. In vivo generated Th1 cells can migrate to B cell follicles to support B cell responses. J. Immunol. 2004; 173: 1640–1646
- Srinath P., Vyas S. P., et al. Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug. Dev. Ind. Pharm. 2000; 26: 312–321
- Trif M., Guillen C., et al. Liposomes as possible cariers for lactoferrin in the local treatment of inflammatory diseases. Exp. Biol. Med. 2001; 226: 559–564
- Trif M., Guillen C., et al. Biodistribution and efficiency of liposome-entrapped lactoferrin in a murine model of established rheumatoid arthritis. Proc. Rom. Acad. 2002; 2: 69–73
- Walmsley M., Katsikis P. D. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 1996; 39(3)495–503
- Ward J. R. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis. Am. J. Med. 1988; 85: 39–44
- Williams A. S., Camilleri J. P., et al. A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. Br. J. Rheumatol 1996; 35: 719–724
- Wooley P. H., Luthra H. S., et al. Type II collagen-induced arthritis in mice. I Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 1981; 154: 688–700